Entrepreneur in Residence
Dr. Lobl works with the new project development group at AMI-USC to help develop and launch University of Southern California technologies which have commercially important potential in the biomedical areas. He works with the AMI team to assess the medical/scientific potential of technologies and to help move forward the technology until it is ready to license to a for-profit company or spin out into a start-up company.
Dr. Lobl has over 45 years of experience in the pharmaceutical and medical device industries and has been involved at the bench and management levels in nearly every aspect of pharmaceutical discovery, research and development from idea generation through clinical trials. Tom’s scientific and research experience is quite broad and includes medicinal and peptide/protein chemistry, drug discovery and development, clinical development, drug and tissue-specific delivery systems in the cancer, inflammatory, infectious, reproductive, and endocrinology diseases areas.
Dr. Lobl began his career at The Upjohn Company (now part of Pfizer) and has worked in both big pharma and a variety of biotech start-up companies in various management positions. In 2002, Tom joined the Al Mann family of companies at AlleCure/Mannkind as VP of Research and Development and subsequently as Senior VP of Research and Development. In January 2004, he helped to start NeuroSystec and was acting CEO for nearly seven years. NeuroSystec was developing an anti-tinnitus drug and was sold to Otonomy. From October 2011 until October 2015, he worked at the Alfred Mann Foundation as an Emerging Technology Strategist. In November 2015, he began working at the Alfred E. Mann Institute at the University of Southern California as Entrepreneur in Residence and as a consultant.
Tom has over 74 publications and patents and has been a scientific reviewer or editorial board member on a variety of scientific journals. He has been a board member and/or officer of a number of scientific organizations and is currently Past Chair of the American Tinnitus Association Board of Directors and on the KGI Advisory Council. He is/has been on a number of NIH grant review study sections (currently on Sensory Technologies) and is a consumer reviewer for the Congressionally Directed Medical Research Program (CDMRP), administered by the Army.
Dr. Lobl has a Bachelor of Science degree in Chemistry from the University of North Carolina, Chapel Hill, a PhD from Johns Hopkins University, and did his post-graduate work at Caltech and Rockefeller University.
Dr. Lobl may be contacted at tom.lobl AT usc DOT edu.